biosimilars News and Resources

Samsung Biologics has announced a three-pillar expansion strategy to establish itself as a global top-tier contract development and manufacturing organisation. Chief executive John Rim presented the company’s achievements and growth strategy at the 2026 J.P. Morgan Healthcare Conference in San